Pamela Stephenson - Jan 19, 2023 Form 4/A - Amendment Insider Report for ALBIREO PHARMA, INC. (ALBO)

Role
Chief Commercial Officer
Signature
/s/ Jason Duncan, Attorney-in-fact
Stock symbol
ALBO
Transactions as of
Jan 19, 2023
Transactions value $
$0
Form type
4/A - Amendment
Date filed
1/27/2023, 04:23 PM
Date Of Original Report
Jan 25, 2023
Previous filing
Jan 9, 2023
Next filing
Jan 23, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALBO Common Stock Award $0 +55K +128.64% $0.00 97.8K Jan 19, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest as to 25% of the shares on January 19, 2024, 6.25% of the shares every three months thereafter beginning on April 19, 2024 and ending on January 19, 2025, and 12.5% of the shares every three months thereafter beginning on April 19, 2025 and ending on January 19, 2026.
F2 Represents 22,242 shares of common stock and 75,513 restricted stock units.

Remarks:

This Form 4/A is being filed solely to correct the vesting schedule of the RSUs granted on January 19, 2023.